HEALTHCBS NEWS
Alibaba probe unearthed evidence it knowingly let dangerous drugs be sold to U.S. consumers
Alibaba and its U.S. payment processing company failed for eight years to stop the sale of dangerous drugs, chemicals, and pill presses to American customers, despite employee warnings about compliance issues. Public records reveal the companies knowingly allowed these hazardous products to be sold.
Mentioned
Related Signal
Adjacent reporting
- Alibaba to pay US $600M to settle allegations it allowed illegal drug and equipment sales
- Alibaba agrees to pay $600 million to settle DOJ probe into illegal drug sales
- Alibaba to pay $600m to settle illegal drug sales allegations in US probe
- FDA finds 'significant violations' committed by major manufacturer of pain relievers, ADHD drugs and anxiety medications
- Stolen devices that failed quality control were sold to the public: FDA
- Alibaba to pay US $600M to settle allegations it allowed illegal drug and equipment sales